MIRA INFORM REPORT

 

 

Report Date :

30.11.2011

 

IDENTIFICATION DETAILS

 

Name :

XENA BIOHERBALS PRIVATE LIMITED

 

 

Registered Office :

3-6-294, Hyderguda, Hyderbad-500029, Andhra Pradesh

 

 

Country :

India

 

 

Date of Incorporation :

06.01.2007

 

 

Com. Reg. No.:

01-052288

 

 

Capital Investment / Paid-up Capital :

Rs.0.100 Million

 

 

CIN No.:

[Company Identification No.]

U74999AP2007PTC052288

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer and Trader of Soy-Isoflavones, Aloe Vera Gel, Powder, Silymarian, etc.

 

 

No. of Employees :

15 [Approximately]

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (26)

 

RATING

STATUS

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Status :

Moderate

 

 

Payment Behaviour :

Unknown

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. the management of the company has not filed its financial of the company with the government department since its inception. However, trade relations are reported as fair. Business is active. Payment terms are not known.

 

The company can be considered for business dealings with some cautions.

 

 

NOTES : Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

 

ECGC Country Risk Classification List – September 30, 2011

                                     

Country Name                       

Previous Rating

(30.06.2011)

Current Rating

(30.09.2011)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INFORMATION DECLINED BY

 

Name :

Mr. Prem Kumar Pushpala

Designation :

Director

Contact No.:

91-9848425596

Date :

10.11.2011

 

 

LOCATIONS

 

Registered Office/ Factory/ Warehouse :

3-6-294, Hyderguda, Hyderbad-500029, Andhra Pradesh, India

Tel. No.:

91-40-65166568 / 23260127 / 23266103

Mobile No.:

91-9848425596 (Mr. Prem Kumar)

Fax No.:

91-40-23229436 / 23266103

E-Mail :

aparna_wagh@rediffmail.com

prem@xenabioherbals.com

sales@xenabioherbals.com

Website :

http://www.xenabioherbals.com

Area :

1500 Sq.ft.

Location :

Owned

 

 

DIRECTORS

 

Name :

Mr. Prem Kumar Pushpala

Designation :

Director

Address :

3-6-294, Hyderguda, Hyderbad-500029, Andhra Pradesh, India

Date of Birth/Age :

15.06.1959

Date of Appointment :

23.02.2009

 

 

Name :

Ms. Pushpala Beena Naidu

Designation :

Director

Address :

3-6-294, Hyderguda, Hyderbad-500029, Andhra Pradesh, India

Date of Birth/Age :

17.04.1958

Date of Appointment :

01.12.2010

DIN :

03292924

 

 

Name :

Mrs. Aparna Devendra Wagh

Designation :

Director

Address :

# 9, Old No.28, Ganapathi Colony, 3rd Street, Cenotaph, 2nd Lane, Teynampet, Chennai – 600018, Tamilnadu, India

Date of Birth/Age :

12.07.1979

Date of Appointment :

06.01.2007

DIN :

00724957

Other Directorship :

 

S.No.

CIN

Name of the Company

Current designation of the director

Date of appointment at current designation

Original date of appointment

Date of cessation

Company Status

Defaulting status

1

U74999AP2007PTC052288

XENA BIOHERBALS PRIVATE LIMITED

Director

6/1/2007

6/1/2007

-

Active

YES

2

U74110TN2007PTC063148

DELTA LEGAL SERVICES PRIVATE LIMITED

Director

17/04/2007

17/04/2007

20/09/2011

Active

NO

3

U65999AP2007PTC055403

NEO INDIAN CORPORATE AND ENTREPRENEURIAL SERVICES PRIVATE LIMITED

Director

5/9/2007

5/9/2007

-

Active

YES

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

Names of Shareholders

 

 

No. of Shares

Aparna Devendra Wagh

 

5000

Saroj Kumar Biswal

 

5000

Total

 

10000

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer and Trader of Soy-Isoflavones, Aloe Vera Gel, Powder, Silymarian, etc.

 

 

Products :

  • Co-Q10
  • Soy-Isoflavones-40%
  • Aloe Vera Gel
  • Powder
  • Silymarian
  • Glucosamine Hcl
  • Curcumin
  • Lycopene
  • Beta-Carotene
  • Beta-Sitosterol
  • Bromelain
  • Borage Oil
  • Bee Pollen
  • Calcium
  • Evening Primrose Oil
  • Genistein
  • Grape Seed Extracts
  • Ipriflavone
  • L-Carnitine
  • L-Arginine
  • Phosphatidylserine
  • Policosanol
  • Squalene
  • Natural Vitamin-E
  • Whey Proteins, etc. 

 

 

Exports :

 

Products :

  • Aloe Vera Gel
  • Soy-isoflavones
  • Curcumin, etc.

Countries :

  • China
  • Sri Lanka
  • Malaysia
  • US
  • Europe

 

 

Imports :

 

Products :

  • Raw Material

Countries :

  • China
  • USA
  • Canada

 

 

Terms :

 

Selling :

Credit [30 Days]

 

 

Purchasing :

Cash

 

 

GENERAL INFORMATION

 

Customers :

  • Wholesalers
  • Retailers
  • End Users
  • OEM’s

 

 

No. of Employees :

15 [Approximately]

 

 

Bankers :

State Bank of India, Andhra Pradesh, India

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Tagore and Company

Chartered Accountant

 

 

Memberships :

·         CIMAP

·         FIXM

 

 

Sister Concern :

·         Beena Enterprise

 

 

CAPITAL STRUCTURE

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

10,000

Equity Shares

Rs. 10/- each

Rs. 0.100 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

 

 

10,000

Equity Shares

Rs. 10/- each

Rs. 0.100 Million

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

Particulars

 

 

31.03.2011

31.03.2010

Sales Turnover [Approximately]

 

110.000

80.000

 

Expected Sales (2011-2012) : Rs.150.000 millions

 

The above information has been parted by Mr. Prem [Director].

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report [Yes/No]

Year of Establishment

Yes

Locality of the Firm

Yes

Construction of the firm

Yes

Premises details

Yes

Type of Business

Yes

Line of Business

Yes

Promoters background

-

No. of Employees

Yes

Name of Person Contacted

Yes

Designation of contact person

Yes

Turnover of firm for last two years

Yes

Profitability for last three years

No

Reasons for variation <> 20%

-

Estimation for coming financial year

Yes

Capital the business

No

Details of sister concerns

-

Major Suppliers

No

Major Customers

No

Payment Terms

Yes

Export / Import Details [If Applicable]

Yes

Market Information

-

Litigations that the firm / promoter involved in

-

Banking Details

Yes

Banking Facility Details

No

Conduct of the banking account

-

Buyer visit details

-

Financials, if provided

No

Incorporation details, if applicable

-

Last accounts filed at ROC

-

Major Shareholders, if applicable

-

 

Trade References :

  • Marks and Genetic Private Limited
  • Tanmad Limited

 

Note: The company was a partnership company since 2002 in the name of Xena Bio Herbals then it changed to Private Limited in the name of Xena Bioherbals Private Limited incorporate in January 2007

 

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No records exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                              None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.51.93

UK Pound

1

Rs.80.62

Euro

1

Rs.69.36

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

3

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

3

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

3

--PROFITABILIRY

1~10

3

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

2

--CREDIT LINES

1~10

2

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

NO

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

YES

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

25

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

RATING

                     

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.